Cargando…
Ru(II)-Thymine Complex Causes Cell Growth Inhibition and Induction of Caspase-Mediated Apoptosis in Human Promyelocytic Leukemia HL-60 Cells
Ruthenium-based compounds represent a class of potential antineoplastic drugs. Recently, we designed, synthesized, and identified the Ru(II)-thymine complex [Ru(PPh(3))(2)(Thy)(bipy)]PF(6) (where PPh = triphenylphosphine, Thy = thymine and bipy = 2,2′-bipyridine) as a potent cytotoxic agent with the...
Autores principales: | de Souza Oliveira, Maiara, de Santana, Ádila Angélica Dantas, Correa, Rodrigo S., Soares, Milena Botelho Pereira, Batista, Alzir Azevedo, Bezerra, Daniel Pereira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032384/ https://www.ncbi.nlm.nih.gov/pubmed/29848969 http://dx.doi.org/10.3390/ijms19061609 |
Ejemplares similares
-
A ruthenium-based 5-fluorouracil complex with enhanced cytotoxicity and apoptosis induction action in HCT116 cells
por: Silva, Valdenizia Rodrigues, et al.
Publicado: (2018) -
pH homeostasis in promyelocytic leukemic HL60 cells
Publicado: (1988) -
Ru(II)-thymine complex causes DNA damage and apoptotic cell death in human colon carcinoma HCT116 cells mediated by JNK/p38/ERK1/2 via a p53-independent signaling
por: Silva, Suellen L. R., et al.
Publicado: (2019) -
Eosinophilic differentiation of the human promyelocytic leukemia cell line, HL-60
Publicado: (1984) -
Apoptosis Induction by Menadione in Human Promyelocytic Leukemia HL-60 Cells
por: Sa, Duck-Jin, et al.
Publicado: (2009)